Sign inJoin waitlistJoin the waitlist

Saul Rosenberg

Professor of Lymphoma · Stanford Health Care

Credentials: · ·

History

Stanford Health Care
Present
Stanford Health Care
Present

Infectious Disease
1956–1958
Case Western Reserve University
1953–1956
Case Western Reserve University School of Medicine
1949–1953

Research

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes
The Journal of Experimental Medicine · 1982 · Last of 4 authors · 2,506 citations
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993
Journal of Clinical Oncology · 1999 · Last of 13 authors · 1,620 citations
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting
Journal of Clinical Oncology · 1989 · 1,196 citations

Richard Hoppe
43 papers
Eli Glatstein
34 papers · 2 as a resident
Michael Lotze
29 papers
Sandra Horning
27 papers
AC
Alfred Chang
16 papers · 1 as a resident
Ranjana Advani
15 papers
Suzanne Topalian
15 papers
CP
Carol Portlock
14 papers
AM
Amitabha Mazumder
10 papers · 10 as a fellow
Marston Linehan
10 papers
AE
Andrew Eisenthal
9 papers
SE
Stephen Ettinghausen
9 papers · 6 as a resident

Grants

Training Program in Investigative Oncology
National Cancer Institute · T32
Contact PI · $1.9M · Stanford University
1978–1998
Clinical Investigation in Hodgkin's Disease
National Cancer Institute · R01
Contact PI · $400.8K · Stanford University
1992–1997
Clinical and Laboratory Studies of Malignant Lymphomas
National Cancer Institute · P01
Contact PI · $8.5M · Stanford University
1983–1991
Consortium Cancer Center Support Grant
National Cancer Institute · P30
Contact PI · $635.8K · Cancer Prevention Instit of California
1983–1986